<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The most frequent type of <z:hpo ids='HP_0008905'>rhizomelic dwarfism</z:hpo>, <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> (ACH), is caused by mutations in the fibroblast growth factor receptor 3 (FGFR3) gene </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in FGFR3 result in <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> of <z:hpo ids='HP_0003828'>variable severity</z:hpo>, including mild phenotypic effects in hypochondroplasia (<z:chebi fb="1" ids="24536">HCH</z:chebi>), severe phenotypic effects in thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> types I (<z:chebi fb="0" ids="53555">TDI</z:chebi>) and II (TDII), and severe but survivable phenotypic effects in severe <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> with <z:hpo ids='HP_0001263'>developmental delay</z:hpo> and <z:hpo ids='HP_0000956'>acanthosis nigricans</z:hpo> (SADDAN) </plain></SENT>
<SENT sid="2" pm="."><plain>To explore the molecular mechanisms that result in the different phenotypes, we investigated the kinetics of mutated versions of FGFR3 </plain></SENT>
<SENT sid="3" pm="."><plain>First, we assayed the phosphorylation states of the mutated FGFR3s and found that the level of phosphorylation in <z:chebi fb="0" ids="53555">TDI</z:chebi>-FGFR3 was lower than in ACH-FGFR3, although the other mutants were phosphorylated according to phenotypic severity </plain></SENT>
<SENT sid="4" pm="."><plain>Second, we analyzed the duration of the phosphorylation </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="53555">TDI</z:chebi>-FGFR3 was not highly phosphorylated under ligand-free conditions, but the peak phosphorylation levels of <z:chebi fb="0" ids="53555">TDI</z:chebi>-FGFR3 and ACH-FGFR3 were maintained for 30 min after stimulation with FGF-1 </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, ligand-dependent phosphorylation of <z:chebi fb="0" ids="53555">TDI</z:chebi>-FGFR3, but not ACH-FGFR3, lasted for more than 8 h after FGF-1 administration </plain></SENT>
<SENT sid="7" pm="."><plain>The other mutant proteins showed sustained phosphorylation independent of ligand presence </plain></SENT>
<SENT sid="8" pm="."><plain>Third, we investigated the intracellular localization of the mutant proteins </plain></SENT>
<SENT sid="9" pm="."><plain>Immunofluorescence analysis showed accumulations of TDII-FGFR3, SADDAN-FGFR3, and a portion of <z:chebi fb="0" ids="53555">TDI</z:chebi>-FGFR3 in the endoplasmic reticulum (ER) </plain></SENT>
<SENT sid="10" pm="."><plain>Based on these data, we concluded that sustained phosphorylation of FGFR3 causes <z:mp ids='MP_0002657'>chondrodysplasia</z:mp>, and the phenotypic severity depends on the proportion of ER-localized mutant FGFR3 </plain></SENT>
<SENT sid="11" pm="."><plain>In FGFR3 signaling, the transcription factor, signal transducer and activator of transcription 1 (STAT1) inhibit proliferation and induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of chondrocytes </plain></SENT>
<SENT sid="12" pm="."><plain>Here we reveal that phospholipase C gamma (PLCgamma) mediates FGFR3-induced STAT1 activation </plain></SENT>
<SENT sid="13" pm="."><plain>Both PLCgamma and STAT1 were activated by FGFR3 signaling, but a dominant-negative form of PLCgamma (DN-PLCgamma) remarkably reduced STAT1 phosphorylation </plain></SENT>
<SENT sid="14" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> assays revealed that the constitutively active forms of FGFR3 (TDII-FGFR3) and STAT1 (STAT1-C) induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of chondrogenic ATDC5 cells via caspase activity </plain></SENT>
<SENT sid="15" pm="."><plain>DN-PLCgamma reduced the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of ATDC5 cells expressing TDII-FGFR3, but over-expression of both DN-PLCgamma and STAT1-C induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="16" pm="."><plain>Therefore, we conclude that a PLCgamma-STAT1 pathway mediates apoptotic signaling by FGFR3 </plain></SENT>
</text></document>